| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |